AIM ImmunoTech
AIM

AIM ImmunoTech (AIM) earnings history

Most recent quarter

Period end
Jun 30, 2025
EPS actual
−$1,941.10
EPS estimate
−$4,219.78
Revenue
$25,000.00
Revenue estimate
$100,000.00
Reported
Aug 14, 2025

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q2 2025Aug 14, 2025−$4,219.78−$1,941.10+54.00%$25,000.00SEC
Q4 2024Mar 27, 2025−$4,747.25−$5,274.73−11.11%$0.00SEC
Q3 2024Nov 14, 2024−$3,164.84−$3,164.84+0.00%$0.00SEC
Q2 2024Aug 14, 2024−$6,505.49−$1,582.42+75.68%$25,000.00SEC
Q1 2024May 15, 2024−$5,802.20−$6,329.67−9.09%$40,000.00SEC
Q4 2023Apr 1, 2024−$6,329.67−$13,714.29−116.67%$62,000.00SEC
Q3 2023Nov 14, 2023−$5,978.02−$8,439.56−41.18%$46,000.00SEC
Q2 2022Aug 15, 2022−$3,868.13−$5,274.73−36.36%$15,000.00
Q4 2021Mar 31, 2022−$4,923.08−$6,329.67−28.57%$51,000.00
Q4 2020Mar 31, 2021−$3,868.13−$5,274.73−36.36%$42,000.00
Q1 2020May 14, 2020−$7,032.97−$11,604.40−65.00%$45,000.00

Quarterly revenue

Q1 2020
$45,000.00
Q4 2020
$42,000.00
Q4 2021
$51,000.00
Q2 2022
$15,000.00
Q3 2023
$46,000.00
Q4 2023
$62,000.00
Q1 2024
$40,000.00
Q2 2024
$25,000.00
Q3 2024
$0.00
Q4 2024
$0.00
Q2 2025
$25,000.00

Frequently asked questions

  • When did AIM ImmunoTech (AIM) last report earnings?

    AIM ImmunoTech last reported on Aug 14, 2025, covering fiscal Q2 2025.

  • Did AIM beat earnings estimates?

    Yes. AIM ImmunoTech reported EPS of −$1,941.10 for Q2 2025 against a −$4,219.78 estimate — a 54.00% beat.

  • How much revenue did AIM report last quarter?

    AIM ImmunoTech reported $25,000.00 in revenue for Q2 2025, against a consensus estimate of $100,000.00.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.